Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancer

Article English OPEN
Bohanes, Pierre; Courvoisier, Delphine; Perneger, Thomas; Morel, Philippe; Huber, Olivier; Roth, Arnaud;
  • Journal: issn: 1424-7860
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.4414/smw.2011.13249
  • Subject: Adult | Aged | Antineoplastic Combined Chemotherapy Protocols/therapeutic use | Carcinoembryonic Antigen/blood | Disease-Free Survival | European Continental Ancestry Group | Female | Humans | Male | Middle Aged | Neoplasm Metastasis | Prognosis | Proportional Hazards Models | Retrospective Studies | Stomach Neoplasms/drug therapy/pathology/surgery
    • ddc: ddc:616 | ddc:617

There are very limited data suggesting a benefit for second-line chemotherapy in advanced gastric cancer. Therefore, the number of patients who receive further treatment after failure of first-line chemotherapy varies considerably, ranging from 14% to 75%. In the absenc... View more
Share - Bookmark